Loading...
Please wait, while we are loading the content...
Similar Documents
Cancer biomarkers: easier said than done.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Pritzker, Kenneth P. H. |
| Copyright Year | 2002 |
| Abstract | BACKGROUND Biological and technical advances have led to greatly increased research and development of cancer biomarkers. This overview lists some of the challenges and barriers to developing novel effective cancer biomarkers and enablers to facilitate cancer biomarker development. METHODS Current scientific literature regarding development of biomarkers for cancer and other diseases was reviewed. RESULTS Challenges to developing cancer biomarkers include better understanding of biological heterogeneity, including host/tumor heterogeneity; analytical factors, such as interferences and analytical sensitivity; clinical pathologic factors, such as current histopathologic standards; and health service and market factors. More standardized biomarker definitions, standardization of cancer biology terminology, and high-quality reference materials (specimen and clinical data repositories) were identified as factors required to support advances in cancer biomarkers. CONCLUSIONS With the above enablers, novel cancer biomarkers may be useful, both for assessing early and established neoplasia more precisely and for contributing data toward development of novel practical concepts regarding cancer biology. |
| File Format | PDF HTM / HTML |
| DOI | 10.1093/clinchem/48.8.1147 |
| PubMed reference number | 12142366 |
| Journal | Medline |
| Volume Number | 48 |
| Issue Number | 8 |
| Alternate Webpage(s) | http://clinchem.aaccjnls.org/content/clinchem/48/8/1147.full.pdf |
| Alternate Webpage(s) | https://doi.org/10.1093/clinchem%2F48.8.1147 |
| Journal | Clinical chemistry |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |